HomeOpen Access NewsOAG 035 - July 2022

OAG 035 - July 2022

The challenge of treating genetic diseases: The example of creatine transporter deficiency

The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.

Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer

Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.

Accelerating design & manufacture in the eye care sector

Nick Walsh, updates us on the fast-moving developments in the eye care sector, specifically on the design & manufacture of frames for glasses.

European innovation potential knows no bounds

Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, calls attention to building a pan-European innovation potential ecosystem in health served with top-notch infrastructures.

Can vitamin D help combat the effects of preeclampsia?

Shona Wilkinson at Nutrigums explains how vitamin D could be the secret weapon to combating the effects of preeclampsia.

Minimising impacts of coastal construction on bottlenose dolphins

Dolphin Behaviourist and Biostatistician gives insight into the impacts of coastal construction, ensuring quality of coastal life for dolphins

Model systems of medicolegal death investigation

Chief Medical Examiner Victor W. Weedn, MD, JD, highlights the ways in which medicolegal death investigation (MDI) systems vary widely in the U.S. and the world.

A fascinating look at optimal leisure lifestyle

Robert Stebbins, Professor Emeritus at University of Calgary in Alberta, takes a fascinating look at what we need to know about optimal leisure lifestyle

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders